Literature DB >> 4330291

Ganglioside inactivation of botulinum toxin.

L L Simpson, M M Rapport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4330291     DOI： 10.1111/j.1471-4159.1971.tb00235.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  19 in total

1.  Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 2.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.

Authors:  S Kozaki; J Ogasawara; Y Shimote; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  A note on the specific fixation, specific deactivation and non-specific inactivation of bacterial toxins by gangliosides.

Authors:  W E van Heyningen; J Mellanby
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord.

Authors:  E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins.

Authors:  Lisheng Peng; Ronnie P-A Berntsson; William H Tepp; Rose M Pitkin; Eric A Johnson; Pål Stenmark; Min Dong
Journal:  J Cell Sci       Date:  2012-03-27       Impact factor: 5.285

Review 7.  Unique ganglioside binding by botulinum neurotoxins C and D-SA.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

8.  Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines.

Authors:  N Yokosawa; Y Kurokawa; K Tsuzuki; B Syuto; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

9.  Direct evidence for the specific fixation of Cl. botulinum A neurotoxin to brain matter.

Authors:  E Habermann; I Heller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

10.  Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function.

Authors:  Roland W M Bullens; Graham M O'Hanlon; Eric Wagner; Peter C Molenaar; Keiko Furukawa; Koichi Furukawa; Jaap J Plomp; Hugh J Willison
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.